Terminal · Institutions

Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.

Parkman Healthcare Partners LLC 13F Holdings -- Portfolio & Top Positions (2026-06-30)

Parkman Healthcare Partners LLC (CIK 1777015) reported $976.8M across 76 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: MBX ($44.2M, 4.52%), LLY ($42.0M, 4.30%), CVS ($40.5M, 4.15%), DXCM ($36.0M, 3.69%), PTCT ($35.5M, 3.64%). Source: SEC Form 13F.

RankTickerCompanyValue% PortfolioSharesAction
1MBXMBX BIOSCIENCES INC$44.2M4.52%800,173Added
2LLYELI LILLY & CO$42.0M4.30%35,000Added
3CVSCVS HEALTH CORP$40.5M4.15%391,791Added
4DXCMDEXCOM INC$36.0M3.69%534,767Trimmed
5PTCTPTC THERAPEUTICS INC$35.5M3.64%435,691Added
6RCUSARCUS BIOSCIENCES INC$28.3M2.90%919,266Trimmed
7GPCRSTRUCTURE THERAPEUTICS INC$26.1M2.67%485,661Added
8VRDNVIRIDIAN THERAPEUTICS INC$25.3M2.59%1.4MAdded
9AGIOAGIOS PHARMACEUTICALS INC$24.8M2.54%669,046Added
10INBXINHIBRX BIOSCIENCES INC$24.3M2.49%256,950New
11XENEXENON PHARMACEUTICALS INC$24.0M2.46%397,379Trimmed
12EWTXEDGEWISE THERAPEUTICS INC$23.4M2.40%577,036Added
13UNHUNITEDHEALTH GROUP INC$23.2M2.38%55,921New
14SYKSTRYKER CORPORATION$21.4M2.19%67,973Trimmed
15IQVIQVIA HLDGS INC$20.4M2.09%105,811Added
16ZBHZIMMER BIOMET HOLDINGS INC$20.0M2.05%232,557Trimmed
17PODDINSULET CORP$20.0M2.05%131,378Trimmed
18ASMBASSEMBLY BIOSCIENCES INC$19.8M2.03%721,181Added
19SNDXSYNDAX PHARMACEUTICALS INC$19.2M1.96%877,256Trimmed
20EYPTEYEPOINT INC$18.4M1.89%1.3MTrimmed
21THCTENET HEALTHCARE CORP$18.2M1.86%97,280Added
22LIVNLIVANOVA PLC$17.3M1.77%210,529Trimmed
23ANIPANI PHARMACEUTICALS INC$16.8M1.72%202,907Trimmed
24BCRXBIOCRYST PHARMACEUTICALS INC$16.2M1.66%1.6MTrimmed
25ALNYALNYLAM PHARMACEUTICALS INC$15.3M1.56%50,672Added

Source: SEC Form 13F filings · as of 2026-06-30